FDA On-Site Audit Successfully Completed
发布时间：
2024-07-01 00:34:43
From June 3 to June 8, 2024, Mr. Matthew Clabeaux, an inspector from the U.S. FDA, conducted an on-site audit of our company. During the five-day audit, the inspector performed a comprehensive and thorough examination of six major quality systems: material control, production management, facilities and equipment, and quality management.
This FDA audit covered six active pharmaceutical ingredients (APIs), including BP-3 and UVT. It fully demonstrated Huayang Chemical’s comprehensive capabilities in API production and quality management, laying a solid foundation for the company’s global market expansion.
The successful completion of this FDA on-site audit is attributed to the dedication and tireless efforts of all colleagues. We sincerely thank everyone who contributed to and supported this audit.
